Summary Lipid peroxidation products can be cytotoxic. Our objectives were (1) to use two pro-oxidants (iron and a pro-oxidative drug) to selectively increase lipid peroxidation in the implanted human breast tumours of mice consuming fish oil and (2) to kill the cancer cells without harming normal host tissues. The theoretical basis for selective cytotoxicity is that normal cells are better able to handle oxidative stress than cancer cells. Male athymic nude mice, consuming an AIN-76 diet, were injected s.c. with MDA-MB 231 human breast carcinoma cells. Three weeks later, all mice had palpable tumours, 3-10 mm in diameter, and diets were changed to modified AIN-76 diets containing 19% menhaden fish oil and 1% corn oil with or without supplemental 0.3% ferric citrate. After 2 weeks, half of the mice on each diet (19% fish oil with or without supplemental ferric citrate) were injected (three times per week for 2 weeks) with the ether-lipid drug edelfosine (ET-18-OCH3). The concentration of lipid peroxidation products in tumours (as measured by thiobarbituric acid-reactive substances, TBARS) was significantly increased by both ferric citrate and ET-18-OCH3. The TBARS in livers were not increased, nor was there evidence of other harmful side-effects to the host mice. The addition of iron enhanced tumour cell death whereas ET-1 8-OCH3 suppressed tumour cell mitosis. The use of iron supplementation combined with ET-18-OCH3 resulted in the slowest growth rate, lowest mitotic index, highest level of lipid peroxidation products and increased the cytotoxic index in tumours without detectable harm to the host. That iron supplementation increased tumour suppression beyond that expected from the increase in the concentration of TBARS in the tumour merits further investigation.
Previous studies have revealed that a high level of fish oil in the diet of nude mice can retard the growth or cause regression of implanted human breast cancers (Borgeson et al, 1989; Gonzalez et al, 1991; . The addition of iron to the diet of mice consuming fish oil further suppressed tumour growth (Gonzalez et al, 1991) . One proposed mechanism for the tumour regression under these dietary conditions is that cancer cell death results from an increase in the products of lipid peroxidation following consumption of fish oil (Gonzalez et al, 1991) . When fish oil is consumed, the highly polyunsaturated fatty acids (HPUFAs) from the fish oil are rapidly incorporated into the cellular membranes. Lipid peroxidation products are formed when membrane polyunsaturated fatty acids (PUFAs) undergo oxidative damage; this oxidative damage can be enhanced if iron is available to catalyse the production of reactive oxygen species. Free radicals formed during lipid peroxidation may physically damage cellular lipid membranes, proteins and DNA (Masotti et al, 1988) and/or induce cell death by apoptosis (McConkey and Orrenius, 1994) or other forms of cell death. In addition, some of the products of lipid peroxidation (e.g. malondialdehyde, 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal) are directly toxic to the cells in relatively low concentrations (Esterbauer et al, 1991) . Increased lipid peroxida-tion has been thought to kill cancer cells preferentially because the activities of cellular antioxidants that protect normal cells against oxidative damage (i.e. catalase and glutathione peroxidase) may be decreased in cancer cells (Corrocher et al, 1986) . Thus cancer cells are less able than normal cells to inactivate the oxygen radicals formed as a consequence of lipid peroxidation and are therefore less able to survive increased lipid peroxidation.
Results of previous studies using either cultured cells (examples : Begin et al, 1986; Canuto et al, 1991; Grammatikos et al, 1994; Maehle et al, 1995; Padma and Das, 1996) or whole animals (examples: Borgeson et al, 1989; Pritchard et al, 1989 ; Gonzalez et al, 1991; have indicated that an increased exposure to the types of HPUFAs found in fish oil, especially eicosapentanoic acid, kills a variety of cancer cells without killing normal cells, and that addition of an iron-containing compound may increase cell death. However, the question still remains as to whether the most important cause of tumour regression and cell death is: (1) induction of lipid peroxidation; (2) alteration of eicosanoid production; (3) some other mechanisms associated with the alteration in membrane fatty acids or (4) the addition of iron to the diet or culture media.
We reasoned that if lipid peroxidative damage was the main cause of tumour regression then systematically increasing lipid peroxidation in tumours should increase tumour regression and tumour cell death. To test this idea: (1) tumour-bearing nude mice were fed a diet containing fish oil (which is rich in HPUFAs) to provide the substrate for lipid peroxidation in the cancer cells; (2) the fish oil diet was supplemented with a pro-oxidant, ferric citrate, at 0.3% (w/w) to enhance lipid peroxidation; (3) one half of the mice consuming fish oil with supplemental ferric citrate and one half of the mice consuming fish oil without supplemental ferric citrate were treated with the ether-lipid drug edelfosine . ET-18-OCH3 is readily incorporated into cellular membranes and is hypothesized to kill cancer cells by inducing lipid peroxidative damage to the plasma membrane (Wagner et al, 1992) . In support of this mechanism of action for ET-18-OCH3, it has been shown in cell culture studies that: (1) lipid peroxidation was increased by addition of to cell cultures that contained fish oil and ferric citrate and (2) cytotoxicity correlated with the increase in lipid peroxidation when oxidative co-factors (iron and ascorbic acid) were present (Wagner et al, 1992) . Thus, treatment of the host mouse with ET-18-OCH3 in addition to the fish oil and ferric citrate in the diet was expected to increase lipid peroxidation in the tumour.
Briefly, the results of this study indicate that lipid peroxidation was significantly increased by supplementing a 19% fish oil diet with ferric citrate and by periodic injections of ET-18-OCH3. However, iron supplementation to a fish oil diet appears to make an additional contribution to tumour suppression beyond that attributed to the ability of iron to increase the concentration of TBARS in the tumour. The mechanism by which iron supplementation makes this additional contribution to tumour growth suppression has not been elucidated.
MATERIALS AND METHODS Tumour cells
MDA-MB 231 human breast carcinoma cells (American Type Culture Collection, Rockville, MD, USA) were cultured for injection into the tumour-bearing mice. The culture medium was an enriched Ll5:SMEM base media supplemented with other factors as described previously (Moyer and Aust, 1984) . Animals Thirty-six male athymic nude mice (nu/nu, Harlan Sprague Dawley, Madison, WI, USA), 6 weeks old, were used in this study. The mice were housed under aseptic conditions (positive pressure, designated nude mouse room, sterilized cages with microisolator tops, sterile bedding and water) in a temperature-(24°C) and lightcontrolled (12 h day-') room. All mouse handling was carried out under a laminar flow hood. All animal use and handling was approved by our Institutional Animal Care and Use Committee before commencing the experiment. The animal care facilities are accredited by the American Association for the Accreditation of Laboratory Animal Care.
Experimental design
Cultured MDA-MB 231 cells were harvested, rinsed then suspended in serum-free, L15:SMEM culture medium. Cells in suspension were counted using a Coulter cell counter and the cell count was adjusted to 20 x 106 cells ml-'. The suspension was kept well mixed during the time of injection. Cancer cells (106 cells in 0.05 ml of serum-free culture medium) were injected subcutaneously (s.c.) over each scapula on the upper back of the nude mice. The MDA-MB 231 human breast carcinoma forms tumours after s.c. injection into male nude mice and does not require supplemented hormones for growth. Male mice were used to prevent possible cyclic hormonal influences on tumour growth. The diets were prepared weekly, individual daily portions for each cage were packaged and the packages were stored in sealed containers at -20°C to suppress spontaneous lipid peroxidation. (Wagner et al, 1992) . A non-lethal dose of ET-18-OCH3, as reported in a previous study (Leder et al, 1987) The cytotoxic and mitotic indices were obtained from coded haematoxylin-eosin-stained histological sections of the tumour (see Figure 1 ). All scoring of the coded sections was done by one individual, CWK, without knowledge of the treatment given to the mouse. Cell death was determined by morphological indicators of either apoptosis (marginalization of chromatin to the nuclear envelope, nuclear fragmentation, cytoplasmic shrinkage) or necrosis (pyknotic nucleus, eosinophilic cytoplasm, no cell shrinkage). Mitosis was determined by the presence of mitotic figures. At least 1000 contiguous cells in non-necrotic sections of each tumour were counted. The cytotoxic and the mitotic indices were expressed as the percentage of cells that were undergoing cell death or that were in mitosis respectively.
Sizes of the axillary lymph nodes were recorded when enlargement was detected by palpation. At necropsy, metastatic tumours were found in the axillary lymph nodes of almost all of the mice. These were excised and the tumour cells were identified by histology to be of epithelial origin; however, no further testing has been completed. The lymph node data were not adequate to generate growth curves of lymph node tumours because of the large variation in the ratio of host-tumour tissue in the lymph node. aTwo-way ANOVA of TBARS in the host liver showed that there was no significant difference due to the ET-1 8-OCH3 (column means, P < 0.08) or due to the diet (row means, P = 0.87). There were no significant interactions between the diet and the ET-18-OCH3. bTwo-way ANOVA of TBARS in the implanted human breast carcinoma showed that there was a significant increase because of the ET-1 8-OCH3 (column means, P < 0.004) and due to ferric citrate (row means, P = 0.05). There were no significant interactions between the diet and the ET-1 8-OCH3. cOne-way ANOVA showed that the content of TBARS in the tumours of the group of mice that consumed supplemental ferric citrate and received ET-1 8-OCH3 was significantly greater than that in the tumours of the group that consumed the fish oil diet.
Diagnostic serum enzyme levels were evaluated to determine whether or not there were side-effects (damage to other tissues of the host mouse) because of consumption of any of the diets. The enzymes analysed were (an elevation of a specific enzyme activity indicates damage to the tissues listed in parenthesis; Davidson and Henry, 1974) : alkaline phosphatase (bone, liver); serum glutamic oxaloacetic transaminase (heart, liver, skeletal muscle, kidney); serum glutamic pyruvic transaminase (liver); lactic dehydrogenase (increased with a variety of tissue damage but especially liver damage); amylase (pancreas); creatine phosphokinase (thyroid, brain, lung, heart). These analyses are routine clinical chemistry analyses and were performed by the Clinical Pathology Laboratory at University Hospital (San Antonio, TX, USA). Appropriate controls were used for all tests to establish the linearity of the procedures. The laboratory is certified by the College of American Pathologists.
Statistical analyses
All samples were coded before analyses to minimize bias. SAS statistical software was used for statistical analyses. Tests for normality were performed on each data set. Two-way analysis of variance (ANOVA) followed by one-way ANOVA and Student-Newman-Keuls multiple range tests were used to determine if there were statistically significant (P < 0.05) differences between the groups because of the ferric citrate, the ET-18-OCH3 or interactions between the ferric citrate diet and ET-1 8-OCH3.
Linear regression analysis was used to determine if the increase in the mean tumour volume over the time of the experiment showed a significant linear fit. Slope analysis for differences between the regression of mean tumour volume per group was performed by SAS using the general linear model procedure to generate an ANOVA followed by a T-test between each pair of lines against the null hypothesis that there was no difference between the slopes. A P-value < 0.05 was used to indicate that there was a significant difference between slopes of the regression lines, and thus that the tumour growth rates represented by the slopes were significantly different.
RESULTS
Dietary modifications and ET-18-OCH3on the tumour-bearing host mouse ANOVA showed that there were no significant differences between experimental groups of mice in: (1) body weight ( Table 4 for the summary of statistical analyses of 0.3% ferric citrate was 173.0 ± 10.9 mg d11. ANOVA revealed that these serum iron levels were not significantly different. aThe composition of the diets is listed in Table 1 . bSlope of the best fit linear regression line ± s.e. of that slope. cThe slope of the line of groups 1 and 2 shows a significant (P < 0.05), positive linear fit by linear regression analysis. The slope of the line of groups 3 and 4 is not significantly different from 0. rThe growth rates (slopes) were compared by SAS using a general linear model to generate an analyses of variance followed by a T-test against the null hypothesis that there was no difference between the slopes of each pair of lines. P < 0.05 was used to indicate significant differences. (9) 8.14 ± 1.14b Column means 7.6 ± 1.71 6.5 ± 0.76 aTwo-way ANOVA revaled a significant difference in the mitotic index in the tumour because of the ET-1 8-OCH3 treatment (column means, P = 0.006). there was no significant difference in the mitotic index as a result of the diets (row means, P = 0.80). bTwo-way ANOVA revealed a marginally significant increase in the cytotoxic index in the tumour as a result of the consumption of ferric citrate (row means, P = 0.053). There was no significant difference in the cytotoxic index due to the ET-1 8-OCH3 treatment (column means, P = 0.62).
British Journal of Cancer (1997) Dietary modification and ET-18-OCH3 on the implanted human breast carcinoma Two-way ANOVA (Table 3) of the concentration of TBARSs in the implanted human breast carcinoma revealed that there was a significant increase in TBARS because of the ferric citrate supplementation (P = 0.05) and ET-18-OCH3 (P < 0.004).
The mean tumour volume of each group was normalized to a volume of 0 at the beginning of the fish oil diets. This was accomplished by subtracting the mean tumour volume at the beginning of the fish oil from the tumour volume at that time and at each subsequent measurement. The normalized mean daily tumour volume for each dietary group plotted as a function of the number of days after initiation of the fish oil diet is presented in Figure 2 . Least-squares linear regression analyses of tumour volume vs time showed that the tumour growth rate was significantly less because of addition of ferric citrate or because of treatment with ET-18-OCH3 (summarized in Table 4 ). Figure 2 illustrates that there was not a significant increase in the mean tumour volume of mice that consumed high fish oil plus ferric citrate (with or without ET-18-OCH3), thus the mean tumour growth of these two groups was nil.
The mitotic and cytotoxic indices (per cent of cells in mitosis or per cent of dying cells respectively) were determined from 4-gmthick histological sections of non-necrotic areas of the tumour. Two-way ANOVA of the mitotic index (Table 5 , row means) revealed that the ferric citrate supplementation to the diet of the mice did not significantly alter the mitotic index in the tumours. However, ET-18-OCH3 treatment did significantly (P < 0.05) decrease the mitotic index (Table 5, TBARS (nmol mg-1 protein) Figure 3 The linear regression analyses (± 95% confidence interval) of concentration of lipid peroxidation products (thiobarbituric acid-reactive substances, TBARS) in MDA-MB 231 human breast carcinomas grown in nude mice against the mean tumour growth rate (mm3 day-'). Diets and treatments are indicated. Error bars indicate s.e.m. for the growth rate of the group (see Table 4 for data), n = 8-10 mice per group. Dashed lines indicate the 95% confidence interval for the regression line with the fish oil plus supplemental ferric citrate group excluded from the regression analyses as it is outside the 95% confidence interval. The slope of the regression line = -8.80, Pfor slope = 0.05 the results of one-way ANOVA demonstrated that consumption of the diet containing high fish oil plus ferric citrate significantly increased the cytotoxic index in the tumour (row means). There was not a significant difference in the cytotoxic index because of the ET-18-OCH3 treatment (column means).
When interpreting the mitotic, cytotoxic and TBARS values, it should be noted that some tumours regressed because of the diet and/or ET-1 8-OCH3 treatment and were either undetectable or too small to analyse at the time of necropsy. Thus, for these tumours, there was insufflcient or no tumour remaining to analyse for mitotic index, for cytotoxic index or for TBARS content. The lack of measured values on tumours that regressed to the greatest extent influences the ability to detect statistically significant changes in mitotic index, cytotoxic index or TBARS because of the diet and/or the ET-18-OCH3.
DISCUSSION
The main purpose of this study was to evaluate whether increasing lipid peroxidation, as measured by TBARS, in the tumour would correlate with decreased growth rates in implanted human breast carcinomas and to determine if there was detectable harm to the tumour-bearing host mice.
Comparisons with similar past research
The research results in this report are in general agreement with other published findings and we add several new findings. Our results confirm those of earlier reports (Gonzalez et al, 1991 (Gonzalez et al, , 1993 ) that supplementation of the high fish oil diet with a prooxidant, ferric citrate, suppresses breast cancer growth and increases lipid peroxidation products in human breast cancer growing in nude mice. Our original findings are as follows. 1. The significant accumulation of lipid peroxidation products in the breast cancer cells was not accompanied by a significant increase in lipid peroxidation products in the host liver. This indicates that there was selectivity of the intervention between the cancer cells and a representative normal host cell population.
2. Addition of the ether-lipid drug ET-1 8-OCH3 increased lipid peroxidation in the tumour and the increased lipid peroxidation generally correlated with a decreased tumour growth rate. However, dietary supplementation with iron in the form of ferric citrate caused a greater suppression in the growth rate than would be expected from the measured increase in lipid peroxidation. 3. Addition of iron to the fish oil diet caused a significant increase in the cytotoxic index (cell death) of the tumour without a decrease in the mitotic index (rate of cell division), whereas the addition of ET-1 8-OCH3 to the fish oil diet caused a significant decrease in the mitotic index of the tumour without a significant increase in the cytotoxic index.
It therefore seems that iron supplementation and ET-1 8-OCH3 suppress tumour growth via different mechanisms. The exact mechanisms involved remain to be elucidated. This difference between normal cells and cancer cells in the accumulation of lipid peroxidation products is attributed to: compartmentalization and protection from oxygen free radicals; the presence of effective cellular antioxidants; and the effective removal and neutralization of peroxidized lipids by the normal cells (Horrobin, 1994) . In support of the role of increased lipid peroxidation, it has been reported that there is less regression of tumours when lipid peroxidation was suppressed by addition of antioxidants to a diet containing fish oil and ferric citrate (Gonzalez et al, 1991) . It is therefore hypothesized that these fundamental differences in the ability to handle oxidative stress between normal and cancer cells can be exploited to selectively kill the cancer cells with little or no harm to the normal cells.
Role of iron
The graphic presentation of data in Figure 3 shows that increased lipid peroxidation (as measured by TBARSs) is generally negatively correlated with tumour growth. However, the data presented in Figure 3 make clear that tumour growth is not solely dependent on the accumulation of lipid peroxidation products as measured by the concentration of TBARS. The tumour growth rate in the group of mice that consumed fish oil and ferric citrate is suppressed much more than would be expected from the increase in TBARS and in fact is outside the 95% confidence interval for the regression of TBARS against growth rate for the other three groups. This indicates that addition of dietary iron, in the form of ferric citrate, makes an additional contribution to suppression of the tumour growth rate. Apparently, the mechanism by which iron works to cause tumour regression is in addition to iron's ability to enhance the generation of lipid peroxidation products (as measured by TBARS). It is important to recognize that, in addition to malondialdehyde, 4-hydroxynonenal and 4-hydroxyhexenal may also be formed during lipid peroxidation and the formation of these two alkenals might also be enhanced in the presence of iron. These alkenals are detected by the TBARS reaction; however, they may be present and are cytotoxic at micromolar concentrations (Esterbauer et al, 1991) and would constitute but a small fraction of the TBARS. An increase in the localized concentration of these alkenals could in this way increase cell death without a measurable increase in the TBARS level.
The suggestion of another mechanism of how iron worked to make an additional contribution to suppression of carcinoma growth stems from the fact that iron supplementation enhanced the cytotoxic index without lowering the mitotic index. The increased cell death could be because of iron enhanced free radical damage to proteins or to DNA, which would not be measured by TBARS.
Yet another possible mechanism for the effect of iron on tumour cell death could be an increased uptake of iron into the cancer cells. Breast cancer cells often have higher numbers of transferrin receptors than normal breast epithelial cells (Inoue et al, 1993) . Thus, the cancer cells may have sequestered a higher level of iron, resulting in increased damage from the iron even though the mean serum iron was not significantly increased in the group that received supplemental iron. Future research is needed to: elucidate the mechanism(s) by which iron supplementation, in this system, selectively facilitated cancer cell death without suppression of mitotic activity; determine if other types, amounts and preparations of PUFA will be as effective as Menhaden fish oil in tumour suppression; and determine any long-term side-effects of the therapeutic approach. The marked tumour suppressive results obtained in this study clearly warrant further research on this novel and effective approach to breast cancer therapy. The results of this research suggest that a cancer therapy protocol incorporating omega-3 fatty acids and iron might be an effective cancer therapy for humans.
